All times shown are PDT (GMT-7) (San Francisco)
Satellite Channel 2
Non-Commercial Satellite
Room
Satellite Channel 2
Date
Thu, Jul 9, 2020
Time
06:00 AM - 07:00 AM
Session Description
Tuberculosis is the leading cause of mortality among persons living with HIV (PLHIV), accounting for a third of AIDS-related deaths in 2019. While estimates suggest that PLHIV are 19 times more likely to contract TB, case-finding among PLHIV remains low with 49% unaware of their coinfection. WHO-recommended LF-LAM facilitates quicker TB diagnosis and initiation on treatment (or TB preventive therapy for those without active TB) among PLHIV, but uptake of this test in high TB/HIV burden countries has been too slow.
In this session, we will explore barriers to TB diagnosis among PLHIV, spotlight successful adoptions of LF-LAM, highlight results from existing LF-LAM, and preview other diagnostic tools in the pipeline. The session will also include a panel discussion outlining what needs to be done to accelerate access to appropriate tests and treatments to reduce TB-related deaths among PLHIV.
Non-Commercial Satellite
Full Session Recording
Session Name
Room
Satellite Channel 2
Non-Commercial Satellite
The challenge: Screening people living with HIV for TB
Speaker
Session Name
Room
Satellite Channel 2
Non-Commercial Satellite
Overview of updates to global LF-LAM guidance
Session Name
Room
Satellite Channel 2
Non-Commercial Satellite
Scaling LF-LAM: The Kenya experience
Session Name
Room
Satellite Channel 2
Non-Commercial Satellite
Scaling LF-LAM in Zambia
Session Name
Room
Satellite Channel 2
Non-Commercial Satellite
New LF-LAM technology in the pipeline
Speaker
Session Name
Room
Satellite Channel 2
Non-Commercial Satellite
Results from FujiLAM
Speaker
Session Name
Room
Satellite Channel 2
Non-Commercial Satellite
LF-LAM technology and testing on the horizon: Panel and panelist introduction
Speaker
Session Name
Room
Satellite Channel 2
Non-Commercial Satellite
Tools for LF-LAM in development
Speaker
Session Name
Room
Satellite Channel 2
Non-Commercial Satellite
TB co-infection and testing: A personal experience
Speaker
Session Name
Room
Satellite Channel 2
Non-Commercial Satellite
Conclusion and call to action: Commitment for scaling LF-LAM
Speaker
Session Name
Room
Satellite Channel 2